Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

Rhea-AI Summary

Structure Therapeutics (NASDAQ: GPCR), a clinical-stage biopharmaceutical company focused on developing oral small molecule therapeutics for metabolic diseases, has announced its participation in three upcoming healthcare investor conferences.

The company will attend the Guggenheim SMID Cap Biotech Conference on February 5 in New York, featuring a fireside chat at 10:30 a.m. ET, the Leerink Global Healthcare Conference on March 10 in Miami with a fireside chat at 1:00 p.m. ET, and the Jefferies Biotech on the Bay Summit on March 11 in Miami for one-on-one meetings.

Webcasts of the fireside chats will be available on the company's investor relations website, with replays accessible for 90 days following the events.

SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced that management will participate in multiple upcoming healthcare conferences being held in February and March.

Guggenheim SMID Cap Biotech Conference

	Format:	Fireside chat and 1x1 meetings
	Date/time:	Wednesday, February 5 at 10:30 a.m. ET
	Location:	New York, NY
	Webcast link:	https://wsw.com/webcast/guggen2/gpcr/2003892

Leerink Global Healthcare Conference

	Format:	Fireside chat and 1x1 meetings
	Date/time:	Monday, March 10 at 1:00 p.m. ET
	Location:	Miami, FL
	Webcast link:	https://wsw.com/webcast/leerink38/gpcr/2218364

Jefferies Biotech on the Bay Summit

	Format:	1x1 meetings
	Date:	Tuesday, March 11
	Location:	Miami, FL

The live and archived webcasts of the fireside chats will be accessible from the company’s website at https://ir.structuretx.com/events-presentations/events and replays will be available for 90 days.

About Structure Therapeutics 
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, Structure Therapeutics has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world. For additional information, please visit www.structuretx.com.

Investors:
Danielle Keatley
Structure Therapeutics Inc.
ir@structuretx.com

Media:
Dan Budwick
1AB
Dan@1abmedia.com

FAQ

When and where will Structure Therapeutics (GPCR) present at the Guggenheim SMID Cap Conference?

Structure Therapeutics will present at the Guggenheim SMID Cap Biotech Conference on Wednesday, February 5 at 10:30 a.m. ET in New York, NY.

What investor conferences will Structure Therapeutics (GPCR) attend in March 2025?

Structure Therapeutics will attend the Leerink Global Healthcare Conference on March 10 and the Jefferies Biotech on the Bay Summit on March 11, both in Miami, FL.

How long will Structure Therapeutics (GPCR) conference webcasts be available for replay?

The webcasts of the fireside chats will be available for replay on the company's website for 90 days after the events.

Where can investors access Structure Therapeutics (GPCR) conference webcasts?

Investors can access the live and archived webcasts through the company's website at https://ir.structuretx.com/events-presentations/events.

What type of presentations will Structure Therapeutics (GPCR) give at these conferences?

Structure Therapeutics will participate in fireside chats at the Guggenheim and Leerink conferences, and conduct one-on-one meetings at all three conferences, including the Jefferies summit.